Depression and Alzheimer’s disease have comparable pathophysiological processes, such as impaired BDNF, compromised transforming-growth-factor-β1 (TGF-β1) signaling, and abnormal TNF-α signaling. Here, TGFB1 is linked to depressive symptom measurement.